MISSISSAUGA, Ontario, May 05, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, announces that its funding and commercialization partner, Sequel Pharma, LLC (“ Sequel ”), has executed an agreement with a leading international contract development and manufacturing organization (“ CDMO ”) for production of the formulated and packaged drug ( i.e., “ Drug Product ”) of Kinlytic® urokinase...